Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB1 | P20618 | 1/20 | 0.77 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.77 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.77 |
| ▸ | CTSL | P07711 | 9/20 | 0.72 |
| ▸ | CTSB | P07858 | 6/20 | 0.72 |
| ▸ | CTSK | P43235 | 5/20 | 0.69 |
| ▸ | CTSS | P25774 | 2/20 | 0.65 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mg-132 SCHEMBL13436259 | 1.00 | PSMB1 (0.77) | PSMB1PSMB5PSMB2CTSLCTSB | |
| Mg-132 SCHEMBL7862424 | 1.00 | PSMB1 (0.77) | PSMB1PSMB5PSMB2CTSLCTSB | |
| Mg-132 SCHEMBL10006388 | 1.00 | PSMB1 (0.77) | PSMB1PSMB5PSMB2CTSLCTSB | |
| Mg-132 SCHEMBL14579851 | 1.00 | PSMB1 (0.77) | PSMB1PSMB5PSMB2CTSLCTSB | |
| Mg-132 SCHEMBL2522088 | 1.00 | PSMB1 (0.77) | PSMB1PSMB5PSMB2CTSLCTSB | |
| Mg-132 SCHEMBL5062219 | 1.00 | PSMB1 (0.77) | PSMB1PSMB5PSMB2CTSLCTSB | |
| Mg-132 SCHEMBL2535252 | 1.00 | PSMB1 (0.77) | PSMB1PSMB5PSMB2CTSLCTSB | |
| Mg-132 SCHEMBL14514061 | 1.00 | PSMB1 (0.77) | PSMB1PSMB5PSMB2CTSLCTSB | |
| SCHEMBL7710728 | 0.99 | PSMB1 (0.78) | PSMB1PSMB5PSMB2CTSLCTSB | |
| SCHEMBL3054703 | 0.99 | PSMB1 (0.78) | PSMB1PSMB5PSMB2CTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4392 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3841097-B1 | 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER | BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) | 2026-05-20 | — | — | EP | claimed |
| US-20260102417-A1 | COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF CANCER | KEYZELL HOLDING S L (ES) | 2026-04-16 | — | — | US | claimed |
| US-20260069567-A1 | Pharmaceutical Combinations For The Treatment Of Cancer | PRESAGE BIOSCIENCES, INC. (US) | 2026-03-12 | — | — | US | claimed |
| EP-4706663-A2 | FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS | Trustees Of Tufts College (US) | 2026-03-11 | — | — | EP | claimed |
| US-12529162-B2 | Method of screening for peptides capable of binding to a ubiquitin protein ligase (E3) | PHOREMOST LIMITED (GB) | 2026-01-20 | — | — | US | claimed |
| EP-4667458-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER, COMPRISING SOS1 INHIBITOR AND ANTICANCER DRUG | Kanaph Therapeutics Inc. (KR) | 2025-12-24 | — | — | EP | claimed |
| US-20250381202-A1 | PRODRUG KIT FOR MULTI-PRONGED CHEMOTHERAPY | ZOUNEK ALEX (DE) | 2025-12-18 | — | — | US | claimed |
| US-20250367304-A1 | FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS | TUFTS COLLEGE (US) | 2025-12-04 | — | — | US | claimed |
| EP-4648769-A2 | NECROSIS INHIBITOR | Linkgevity Limited (GB) | 2025-11-19 | — | — | EP | claimed |
| EP-3436002-B1 | PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER | PRESAGE BIOSCIENCES INC (US) | 2025-11-05 | — | — | EP | claimed |
| WO-2004004749-A1 | PROTEASEOME INHIBITORS FOR THE TREATMENT OF HERPESVIRIDAE INFECTED INDIVIDUALS | CHARITE - UNIVERSITÄTSMEDIZIN BERLIN (DE) | 2004-01-15 | — | — | WO | claimed |
| WO-2002101012-A9 | REGULATION OF TRANSGENE EXPRESSION FOLLOWING AAV TRANSDUCTION | CHILDREN S HOSPITAL RES FOUNDA (US) | 2003-12-18 | — | — | WO | claimed |
| WO-2003084551-A1 | AGENTS FOR TREATING FLAVIVIRIDAE INFECTIONS | VIROMICS GMBH (DE) | 2003-10-16 | — | — | WO | claimed |
| WO-2003064453-A2 | TROJAN INHIBITORS, METHOD FOR THE PRODUCTION AND USE THEREOF | VIROMICS GMBH (DE) | 2003-08-07 | — | — | WO | claimed |
| EP-1326632-A2 | AGENTS FOR THE TREATMENT OF VIRAL INFECTIONS | VIROMICS GMBH (DE) | 2003-07-16 | — | — | EP | claimed |
| US-20030003583-A1 | Regulation of transgene expression following AAV transduction | CHILDREN'S HOSPITAL RESEARCH FOUNDATION | 2003-01-02 | — | — | US | claimed |
| WO-2002101012-A2 | REGULATION OF TRANSGENE EXPRESSION FOLLOWING AAV TRANSDUCTION | CHILDREN'S HOSPITAL RESEARCH FOUNDATION (US) | 2002-12-19 | — | — | WO | claimed |
| US-20020111314-A1 | Novel stimulation of gene expression and protein synthesis of heat shock protein 72/73 (Hsp 70) | THE TRUSTEES OF COLUMBIA UNIVERSITY (US) | 2002-08-15 | — | — | US | claimed |
| WO-2002030455-A2 | AGENTS FOR THE TREATMENT OF VIRAL INFECTIONS | VIROMICS GMBH (DE) | 2002-04-18 | — | — | WO | claimed |
| US-5942494-A | Stimulation of gene expression and synthesis of heat shock protein 72/73 (HSP 70) | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1999-08-24 | — | — | US | claimed |